Chuanben Chen

1.3k total citations
61 papers, 539 citations indexed

About

Chuanben Chen is a scholar working on Otorhinolaryngology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Chuanben Chen has authored 61 papers receiving a total of 539 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Otorhinolaryngology, 28 papers in Oncology and 27 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Chuanben Chen's work include Head and Neck Cancer Studies (32 papers), Cancer Immunotherapy and Biomarkers (19 papers) and Lung Cancer Treatments and Mutations (10 papers). Chuanben Chen is often cited by papers focused on Head and Neck Cancer Studies (32 papers), Cancer Immunotherapy and Biomarkers (19 papers) and Lung Cancer Treatments and Mutations (10 papers). Chuanben Chen collaborates with scholars based in China, United States and Singapore. Chuanben Chen's co-authors include Jianji Pan, Zhaodong Fei, Jing Lin, Luying Xu, Gang Chen, Zengqing Guo, Yu Zhang, Qisong Chen, Shaojun Lin and Xiuchun Zhang and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Chuanben Chen

56 papers receiving 536 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chuanben Chen China 14 235 181 176 158 103 61 539
Felix Meyer Germany 10 289 1.2× 139 0.8× 117 0.7× 341 2.2× 103 1.0× 20 646
V. Papadimitrakopoulou United States 13 313 1.3× 112 0.6× 304 1.7× 223 1.4× 53 0.5× 41 606
Yu Heng China 15 200 0.9× 79 0.4× 140 0.8× 212 1.3× 177 1.7× 59 651
Derui Li China 15 121 0.5× 84 0.5× 200 1.1× 144 0.9× 162 1.6× 43 522
Jana Halámková Czechia 10 191 0.8× 155 0.9× 108 0.6× 191 1.2× 110 1.1× 36 553
Jiyi Hu China 17 188 0.8× 186 1.0× 271 1.5× 109 0.7× 178 1.7× 52 670
Elena Tornari Italy 9 244 1.0× 48 0.3× 71 0.4× 161 1.0× 61 0.6× 12 431
Sai‐Lan Liu China 15 314 1.3× 383 2.1× 231 1.3× 241 1.5× 200 1.9× 55 752
Xiao‐Guang Ni China 9 198 0.8× 146 0.8× 133 0.8× 142 0.9× 173 1.7× 34 535

Countries citing papers authored by Chuanben Chen

Since Specialization
Citations

This map shows the geographic impact of Chuanben Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chuanben Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chuanben Chen more than expected).

Fields of papers citing papers by Chuanben Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chuanben Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chuanben Chen. The network helps show where Chuanben Chen may publish in the future.

Co-authorship network of co-authors of Chuanben Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Chuanben Chen. A scholar is included among the top collaborators of Chuanben Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chuanben Chen. Chuanben Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Chen, Chuanben, et al.. (2024). Baseline SUVmax is correlated with tumor hypoxia and patient outcomes in nasopharyngeal carcinoma. Scientific Reports. 14(1). 20157–20157. 1 indexed citations
3.
Fu, Xiaobin, et al.. (2024). Role of PET/CT in improving the cost effectiveness of nimotuzumab in nasopharyngeal carcinoma. Acta Otorhinolaryngologica Italica. 44(5). 296–305. 1 indexed citations
4.
Zheng, Fei, et al.. (2023). The effect of primary tumor volume on the prognosis of nasopharyngeal carcinoma in era of volumetric modulated arc therapy: a propensity score matched cohort study. Brazilian Journal of Otorhinolaryngology. 89(3). 374–382. 1 indexed citations
5.
Fei, Zhaodong, et al.. (2023). Significance of radiologic extranodal extension in locoregionally advanced nasopharyngeal carcinoma with lymph node metastasis: a comprehensive nomogram. Brazilian Journal of Otorhinolaryngology. 90(2). 101363–101363. 2 indexed citations
6.
Ye, Feng, Ting Xu, Ziyi Wu, et al.. (2023). Do all patients at the initial stage of nasopharyngeal carcinoma need bone metastasis screening? A retrospective study. Head & Neck. 45(6). 1476–1485. 1 indexed citations
7.
Chen, Chuanben, et al.. (2023). An Immunogenic Cell Death‐Related Gene Signature Reflects Immune Landscape and Predicts Prognosis in Melanoma Independently of BRAF V600E Status. BioMed Research International. 2023(1). 1189022–1189022. 4 indexed citations
9.
Huang, Chuanzhong, Ligen Yu, Imjai Chitapanarux, et al.. (2023). Abnormal variation and prognostic significance of circulating immune cells in patients with nasopharyngeal carcinoma treated with chemoradiotherapy: a prospective cohort study. Translational Cancer Research. 12(12). 3718–3727. 3 indexed citations
11.
Ye, Feng, Ting Xu, Jiawei Chen, et al.. (2022). Recommendation for imaging follow‐up strategy based on time‐specific disease failure for nasopharyngeal carcinoma. Head & Neck. 45(3). 629–637. 2 indexed citations
12.
Chen, Chuanben, et al.. (2020). <p>Comparison of Prognosis Between Juvenile and Adult Nasopharyngeal Carcinoma: A Propensity Score-Matched Analysis</p>. Cancer Management and Research. Volume 12. 8613–8621. 3 indexed citations
13.
Zong, Jingfeng, Bijuan Chen, Qiaojuan Guo, et al.. (2019). Maintenance chemotherapy using S-1 following definitive chemoradiotherapy in patients with N3 nasopharyngeal carcinoma. Radiation Oncology. 14(1). 182–182. 21 indexed citations
15.
Chen, Junqiang, Wenjie Cai, Xiongwei Zheng, et al.. (2017). The pattern of cervical lymph node metastasis in thoracic esophageal squamous cell carcinoma may affect the target decision for definitive radiotherapy. Radiotherapy and Oncology. 123(3). 382–386. 3 indexed citations
16.
Lin, Shaojun, Jianji Pan, Lu Han, et al.. (2013). Long-term outcome of nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiotherapy and chemotherapy. Zhonghua fangshe zhongliuxue zazhi. 22(5). 378–382. 1 indexed citations
17.
Han, Lu, et al.. (2010). Impact of reducing clinical target volume on efficacy of intensity modulated radiation therapy for nasopharyngeal carcinoma. Zhonghua fangshe zhongliuxue zazhi. 19(4). 283–287. 1 indexed citations
19.
Pan, Jianji, Yu Zhang, Shaojun Lin, et al.. (2008). Long-term results of nasopharyngeal carcinoma treated with radiotherapy:1706 cases report. Zhonghua fangshe zhongliuxue zazhi. 17(4). 247–251. 3 indexed citations
20.
Chen, Chuanben, Jianji Pan, & Luying Xu. (2003). [Recombinant adenovirus p53 agent injection combined with radiotherapy in treatment of nasopharyngeal carcinoma: a phase II clinical trial].. PubMed. 83(23). 2033–5. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026